Sarkar Noor Mohammad Siddique, BSc

Mr. Sarkar Noor Mohammad Siddique, BSc

Medical Physics, Toronto Metropolitan University, Toronto, Ontario, Canada
orcid
Scarborough, Ontario, Canada.

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 May 2020 in Applied Sciences
Verified
Journal Article
Open access
PDF file
Sarkar Noor Mohammad Siddique, BScSarkar Noor Mohammad Siddique, BSc
Sarkar Noor Mohammad Siddique, BSc
James C. L. ChowJames C. L. Chow
James C. L. Chow
Nanomaterials are popularly used in drug delivery, disease diagnosis and therapy. Among a number of functionalized nanomaterials such as carbon nanotubes, peptide nanostructures, liposomes and polymers, gold nanoparticles (Au NPs) make excellent drug and anticancer agent carriers in biomedical and cancer therapy application. Recent advances of synthetic technique improved the surface coating of Au NPs with accurate control of particle size, shape and surface chemistry. These make the gold nanomaterials a much easier and safer cancer agent and drug to be applied to the patient’s tumor. Although many studies on Au NPs have been published, more results are in the pipeline due to the rapid development of nanotechnology. The purpose of this review is to assess how the novel nanomaterials fabricated by Au NPs can impact biomedical applications such as drug delivery and cancer therapy. Moreover, this review explores the viability, property and cytotoxicity of various Au NPs.

29 August 2020 in Nanomaterials
Verified
Journal Article
Open access
PDF file
Sarkar Noor Mohammad Siddique, BScSarkar Noor Mohammad Siddique, BSc
Sarkar Noor Mohammad Siddique, BSc
James C. L. ChowJames C. L. Chow
James C. L. Chow
Nanomaterials, such as nanoparticles, nanorods, nanosphere, nanoshells, and nanostars, are very commonly used in biomedical imaging and cancer therapy. They make excellent drug carriers, imaging contrast agents, photothermal agents, photoacoustic agents, and radiation dose enhancers, among other applications. Recent advances in nanotechnology have led to the use of nanomaterials in many areas of functional imaging, cancer therapy, and synergistic combinational platforms. This review will systematically explore various applications of nanomaterials in biomedical imaging and cancer therapy. The medical imaging modalities include magnetic resonance imaging, computed tomography, positron emission tomography, single photon emission computerized tomography, optical imaging, ultrasound, and photoacoustic imaging. Various cancer therapeutic methods will also be included, including photothermal therapy, photodynamic therapy, chemotherapy, and immunotherapy. This review also covers theranostics, which use the same agent in diagnosis and therapy. This includes recent advances in multimodality imaging, image-guided therapy, and combination therapy. We found that the continuous advances of synthesis and design of novel nanomaterials will enhance the future development of medical imaging and cancer therapy. However, more resources should be available to examine side effects and cell toxicity when using nanomaterials in humans.

14 February 2021 in Encyclopedia
Verified
Journal Article
Open access
PDF file
Sarkar Noor Mohammad Siddique, BScSarkar Noor Mohammad Siddique, BSc
Sarkar Noor Mohammad Siddique, BSc
James C. L. ChowJames C. L. Chow
James C. L. Chow
Machine learning (ML) is a study of computer algorithms for automation through experience. ML is a subset of artificial intelligence (AI) that develops computer systems, which are able to perform tasks generally having need of human intelligence. While healthcare communication is important in order to tactfully translate and disseminate information to support and educate patients and public, ML is proven applicable in healthcare with the ability for complex dialogue management and conversational flexibility. In this topical review, we will highlight how the application of ML/AI in healthcare communication is able to benefit humans. This includes chatbots for the COVID-19 health education, cancer therapy, and medical imaging.

17 August 2022 in Nanomaterials
Verified
Journal Article
Open access
PDF file
Sarkar Noor Mohammad Siddique, BScSarkar Noor Mohammad Siddique, BSc
Sarkar Noor Mohammad Siddique, BSc
James C. L. ChowJames C. L. Chow
James C. L. Chow
Cancer theranostics is the combination of diagnosis and therapeutic approaches for cancer, which is essential in personalized cancer treatment. The aims of the theranostics application of nanoparticles in cancer detection and therapy are to reduce delays in treatment and hence improve patient care. Recently, it has been found that the functionalization of nanoparticles can improve the efficiency, performance, specificity and sensitivity of the structure, and increase stability in the body and acidic environment. Moreover, functionalized nanoparticles have been found to possess a remarkable theranostic ability and have revolutionized cancer treatment. Each cancer treatment modality, such as MRI-guided gene therapy, MRI-guided thermal therapy, magnetic hyperthermia treatment, MRI-guided chemotherapy, immunotherapy, photothermal and photodynamic therapy, has its strengths and weaknesses, and combining modalities allows for a better platform for improved cancer control. This is why cancer theranostics have been investigated thoroughly in recent years and enabled by functionalized nanoparticles. In this topical review, we look at the recent advances in cancer theranostics using functionalized nanoparticles. Through understanding and updating the development of nanoparticle-based cancer theranostics, we find out the future challenges and perspectives in this novel type of cancer treatment.

1 July 2020 in Reports of Practical Oncology and Radiotherapy
Verified
Journal Article
Closed access
Sarkar Noor Mohammad Siddique, BScSarkar Noor Mohammad Siddique, BSc
Sarkar Noor Mohammad Siddique, BSc
James C. L. ChowJames C. L. Chow
James C. L. Chow
Artificial intelligence (AI) has already been implemented widely in the medical field in the recent years. This paper first reviews the background of AI and radiotherapy. Then it explores the basic concepts of different AI algorithms and machine learning methods, such as neural networks, that are available to us today and how they are being implemented in radiotherapy and diagnostic processes, such as medical imaging, treatment planning, patient simulation, quality assurance and radiation dose delivery. It also explores the ongoing research on AI methods that are to be implemented in radiotherapy in the future. The review shows very promising progress and future for AI to be widely used in various areas of radiotherapy. However, basing on various concerns such as availability and security of using big data, and further work on polishing and testing AI algorithms, it is found that we may not ready to use AI primarily in radiotherapy at the moment.

30 July 2023 in Cancers
Verified
Journal Article
Open access
PDF file
Sarkar Noor Mohammad Siddique, BScSarkar Noor Mohammad Siddique, BSc
Sarkar Noor Mohammad Siddique, BSc
Harry RudaHarry Ruda
Harry Ruda
James C. L. ChowJames C. L. Chow
James C. L. Chow
Radiotherapy (RT) using ultra-high dose rate (UHDR) radiation, known as FLASH RT, has shown promising results in reducing normal tissue toxicity while maintaining tumor control. However, implementing FLASH RT in clinical settings presents technical challenges, including limited depth penetration and complex treatment planning. Monte Carlo (MC) simulation is a valuable tool for dose calculation in RT and has been investigated for optimizing FLASH RT. Various MC codes, such as EGSnrc, DOSXYZnrc, and Geant4, have been used to simulate dose distributions and optimize treatment plans. Accurate dosimetry is essential for FLASH RT, and radiation detectors play a crucial role in measuring dose delivery. Solid-state detectors, including diamond detectors such as microDiamond, have demonstrated linear responses and good agreement with reference detectors in UHDR and ultra-high dose per pulse (UHDPP) ranges. Ionization chambers are commonly used for dose measurement, and advancements have been made to address their response nonlinearities at UHDPP. Studies have proposed new calculation methods and empirical models for ion recombination in ionization chambers to improve their accuracy in FLASH RT. Additionally, strip-segmented ionization chamber arrays have shown potential for the experimental measurement of dose rate distribution in proton pencil beam scanning. Radiochromic films, such as GafchromicTM EBT3, have been used for absolute dose measurement and to validate MC simulation results in high-energy X-rays, triggering the FLASH effect. These films have been utilized to characterize ionization chambers and measure off-axis and depth dose distributions in FLASH RT. In conclusion, MC simulation provides accurate dose calculation and optimization for FLASH RT, while radiation detectors, including diamond detectors, ionization chambers, and radiochromic films, offer valuable tools for dosimetry in UHDR environments. Further research is needed to refine treatment planning techniques and improve detector performance to facilitate the widespread implementation of FLASH RT, potentially revolutionizing cancer treatment.